A 49-year-old woman walked into my office last fall with a folder. Inside the folder were food logs from the past four years, three different commercial diet program receipts, two CrossFit gym membership cancellations, a bariatric surgery consultation note where she had been told she was "too low BMI" to qualify, and lab work from her primary care that said everything was normal. She had gained 38 pounds in five years. She was eating, by my honest read of her logs, around 1,400 calories a day. She trained four days a week. She was not lying about any of it. Her body had decided, somewhere along the way, that her current weight was the new floor — and was defending it with every metabolic tool available. Leptin resistance was not the only thing happening in her physiology, but it was a useful frame for the conversation we were about to have.
This is the conversation I have constantly. Patients who have done the work, eaten the salads, logged the calories, joined the gyms, and watched the scale stay still or creep up anyway. They are not failing willpower. They are running into a feedback system that was designed to keep humans alive in food scarcity, not to facilitate fat loss in 2027.
What leptin actually does — the mechanism in plain language
Leptin is a hormone produced by adipocytes — fat cells — in proportion to fat mass. It travels to the hypothalamus and tells the brain two things: how much energy is stored, and whether to keep eating. When fat mass is adequate, leptin is high, and the hypothalamus reduces appetite and increases energy expenditure. When fat mass drops, leptin drops, the hypothalamus dials up hunger and dials down expenditure, and the body returns to its prior weight.
That feedback loop works beautifully when it works. The problem arises when the hypothalamus stops listening to the leptin signal. In leptin resistance, leptin levels are high — often very high — but the receptors in the brain no longer respond appropriately. The brain reads the signal as low, and the body responds as if it is starving even when fat mass is abundant. Hunger is amplified. Energy expenditure is suppressed. The set point ratchets up.
The drivers of this resistance are not mysterious:
- Chronic hyperinsulinemia — high insulin downregulates leptin receptor sensitivity. Insulin resistance and leptin resistance travel together.
- Inflammation — particularly hypothalamic inflammation driven by saturated fat excess, fructose, and gut-derived endotoxin. Inflammatory cytokines disrupt leptin signaling at the receptor.
- Sleep deprivation — measurably alters leptin and ghrelin within a single night of restriction, and chronically degrades the responsiveness of both signals.
- Cortisol dysregulation — sustained elevated cortisol promotes visceral fat accumulation, which produces more leptin, which the body then learns to ignore.
- Sex hormone decline — declining estrogen in women and testosterone in men shifts body composition toward central adiposity, which compounds the leptin signaling problem.
Leptin resistance is not a separate disease that needs its own diagnosis code. It is a downstream consequence of a metabolic state that has been ratcheting in the wrong direction for years. The treatment is to address the upstream drivers — not to chase leptin directly.
Why conventional advice fails the mid-life patient
Eat less, move more. Calorie deficit is the only thing that matters. Just be more disciplined. Every patient I see has been told some version of this, and for a healthy 25-year-old with intact metabolic function and normal hormones, it works fine. For a 49-year-old woman with declining estradiol, suboptimal thyroid, fasting insulin of 16, and four years of accumulated metabolic adaptation, it does not work — and continuing to apply it harder produces sarcopenia, hypothyroidism, and a more entrenched defended set point.
The mid-life patient who has been told to eat less and move more for five years has usually lost lean mass, slowed her resting metabolic rate, suppressed her thyroid output, raised her cortisol, and produced exactly the metabolic state that defends the weight she is trying to lose. The advice was not wrong in principle. It was wrong as a sole intervention for the actual physiology in front of us.
How GLP-1 medications fit — and where they do not
GLP-1 receptor agonists — semaglutide, tirzepatide, and the next-generation compounds coming out of Lilly and Novo — work by mimicking a gut hormone the body produces in response to food. They slow gastric emptying, suppress appetite at the brain level, improve insulin sensitivity, and reduce hypothalamic inflammation. The clinical effect for the right candidate is profound. Semaglutide produces roughly 15% body weight loss over 68 weeks across study populations. Tirzepatide produces roughly 21% over similar timeframes.
Where GLP-1 fits well: the patient with insulin resistance, central adiposity, defended set point, and a functional inability to maintain a deficit through behavior alone. For that patient — which is most of the patients I see in the medical weight loss program — GLP-1 is one of the most useful tools in the modern formulary.
Where GLP-1 fails or underperforms: the patient who already has athletic body composition and minimal insulin resistance; the patient whose hormonal picture (low thyroid, low estradiol or testosterone, dysregulated cortisol) is the dominant driver and is not being addressed in parallel; the patient who is not paired with adequate protein intake and resistance training and who consequently loses muscle alongside fat; the patient who stops abruptly without a maintenance plan and rebounds.
The patients I see who underperform on GLP-1 almost universally fall into one of those categories. The medication did not fail them. The framework around the medication failed them.
What I look for in the workup
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
When a patient presents for a medical weight loss program consultation, the workup is broader than what most patients have had before. The lab panel typically includes:
- Metabolic markers: fasting insulin (the single most useful number most providers do not order), HbA1c, fasting glucose, comprehensive metabolic panel, lipid panel with apoB and Lp(a), uric acid
- Sex hormones: total and free testosterone, SHBG, estradiol, progesterone (with cycle timing in pre-menopausal women), DHEA-S
- Thyroid panel: TSH, free T3, free T4, reverse T3, thyroid antibodies
- Cortisol pattern when the picture suggests dysregulation — AM serum at minimum, four-point salivary or DUTCH if warranted
- Inflammatory and nutritional: hs-CRP, ferritin, vitamin D, B12, magnesium, homocysteine
- Body composition: DEXA when indicated. BMI alone is a poor screen — what matters is fat mass, lean mass, and visceral fat.
The history that goes with the labs is detailed: prior weight loss attempts and their outcomes, medication and supplement history, sleep, alcohol, stress patterns, dietary patterns, exercise patterns, family history of metabolic disease. I want to know what worked partially, what did not work at all, and why each attempt ended.
How the 90-day program actually proceeds
The structured phase of the medical weight loss program is 90 days. That is enough time to complete a workup, initiate interventions, get to the first reassessment, and establish patterns that hold beyond the structured phase.
Days 1-30 are diagnostic and initiation. Lab work, history, body composition, and the candidacy conversation. If GLP-1 therapy is part of the plan, it starts at a conservative dose — usually 0.25 mg semaglutide weekly or the equivalent tirzepatide starter — and titrates up only as tolerance allows. Adjacent interventions (hormone optimization, thyroid support, nutritional counseling) are layered in deliberately rather than all at once.
Days 30-60 are titration and adjustment. GLP-1 dose moves up if tolerance allows. We reassess body composition to confirm we are losing fat and not lean mass. Protein intake is reinforced — I push patients toward 1.2-1.6 g/kg of ideal body weight, distributed across the day. Resistance training is non-negotiable.
Days 60-90 are optimization and the maintenance design. Lab work re-runs. Body composition re-measures. The maintenance plan is built deliberately — tapering GLP-1, transitioning to maintenance dosing, locking in the dietary and training patterns that have produced the response, and identifying what continues beyond day 90.
The most common failure pattern in medical weight loss is not the structured phase. It is what happens after. We design the post-90-day phase before it arrives, not when patients show up six months later having regained.
How I evaluate whether GLP-1 is the right tool
Not every patient gets a GLP-1 prescription. When I evaluate candidacy I am looking at:
- BMI and body composition — DEXA helps significantly here
- Insulin and HbA1c — strong insulin resistance points toward GLP-1; minimal insulin resistance points away
- Hormonal picture — sometimes the right first move is hormone optimization, with GLP-1 added later if needed
- Contraindications — personal or family history of medullary thyroid carcinoma, MEN2 syndrome, prior pancreatitis are absolute exclusions
- Patient capacity for the protein and resistance training piece — GLP-1 without that scaffolding produces sarcopenia, and I would rather not start the medication than start it without the framework
For a patient who is not a GLP-1 candidate, the levers are still available. Hormone optimization, thyroid correction, structured nutritional support, sleep intervention, and resistance training produce meaningful results when applied as a coordinated plan. GLP-1 is one tool among several, not the entire toolkit.
How to actually move forward
If you have been fighting with weight that does not respond to what used to work — and the conversation in your head sounds anything like the patient from the opening — the next step is a weight loss assessment and a real consultation. Bring your prior weight loss data, any recent labs, your medication and supplement list, and a brief summary of what you have already tried.
Book at the Columbus clinic or the Warner Robins clinic through online booking. The first visit is the workup. The second visit is the lab review and the plan. From there we run the 90 days with regular check-ins, and we adjust based on what your physiology actually does — not what the protocol predicts on paper.
The patient with the folder lost 47 pounds over the following 14 months. GLP-1 was part of it. Estradiol and progesterone replacement was part of it. A thyroid adjustment was part of it. Doubling her protein and adding two days of real resistance training was part of it. None of those interventions individually would have moved her. The combination did. That is the model.
*This article is educational and does not constitute medical advice. Medical weight loss requires clinical evaluation and ongoing monitoring. Individual results vary.*
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.